Product NDC: | 0005-2500 |
Proprietary Name: | FIBERCON |
Non Proprietary Name: | CALCIUM POLYCARBOPHIL |
Active Ingredient(s): | 625 mg/1 & nbsp; CALCIUM POLYCARBOPHIL |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0005-2500 |
Labeler Name: | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | part334 |
Marketing Category: | OTC MONOGRAPH NOT FINAL |
Start Marketing Date: | 20040105 |
Package NDC: | 0005-2500-23 |
Package Description: | 140 TABLET in 1 BOTTLE (0005-2500-23) |
NDC Code | 0005-2500-23 |
Proprietary Name | FIBERCON |
Package Description | 140 TABLET in 1 BOTTLE (0005-2500-23) |
Product NDC | 0005-2500 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | CALCIUM POLYCARBOPHIL |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20040105 |
Marketing Category Name | OTC MONOGRAPH NOT FINAL |
Labeler Name | Wyeth Pharmaceutical Division of Wyeth Holdings Corporation, a subsidiary of Pfizer Inc. |
Substance Name | CALCIUM POLYCARBOPHIL |
Strength Number | 625 |
Strength Unit | mg/1 |
Pharmaceutical Classes |